Please use this identifier to cite or link to this item:
|Title:||Clinical pharmacology and pharmacogenetics of gemcitabine|
|Citation:||Wong, A., Soo, R.A., Yong, W.-P., Innocenti, F. (2009-05). Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metabolism Reviews 41 (2) : 77-88. ScholarBank@NUS Repository. https://doi.org/10.1080/03602530902741828|
|Abstract:||Gemcitabine is a cytotoxic nucleoside analog, which is widely used in the treatment of malignancies. Interindividual differences in gemcitabine pharmacokinetics and pharmacodynamics have been demonstrated. Pharmacogenetic factors may account for a significant proportion of these differences. This review provides an update on the pharmacogenetics of gemcitabine and its influence on gemcitabine efficacy and toxicity. © 2009 Informa UK Ltd.|
|Source Title:||Drug Metabolism Reviews|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 17, 2018
WEB OF SCIENCETM
checked on May 16, 2018
checked on Jun 1, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.